KETOBREL (Micro Labs Pty Ltd)
Product name
KETOBREL
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
126 (255 working days)
Active ingredients
ketorolac trometamol
Registration type
New generic medicine
Indication
KETOBREL eye drops are indicated for the short term (2-4 weeks) relief of symptoms of seasonal allergic conjunctivitis.
KETOBREL eye drops are also indicated for the short term (2-4 weeks) prophylaxis and reduction in inflammation in patients undergoing cataract extraction.